Ricky, Author at FACIT

Registration is now open for the 2024 Falcons’ Fortunes Pitch Finals – LIVE!

Posted on March 12, 2024 (May 6, 2024)

March 12, 2024 – You are invited to attend Falcons’ Fortunes, FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research and innovation communities. Now in its 11th year, the Falcons’ Fortunes event features six Ontario rising stars pitching their breakthrough cancer innovation as they compete for the $100,000 Ernsting Entrepreneurship Award.

FACIT and OBIO® partner on women-focused seed capital and entrepreneurship program

Posted on March 8, 2024 (May 24, 2024)

March 8, 2024 – On International Women’s Day, FACIT and OBIO® are pleased to announce a new partnership in the Ontario life sciences ecosystem, built on their common goal to drive entrepreneurial and commercialization mandates to address the unmet needs and barriers faced by female entrepreneurial leaders in STEM.

FACIT portfolio company Tenomix secures an all-Canadian investment round for colorectal cancer diagnostic

Posted on March 1, 2024 (March 20, 2024)

March 1, 2024 – FACIT congratulates London, Ontario based Tenomix Inc. (“Tenomix”) on successfully reaching a key milestone in closing its latest financing round to help propel the medtech start-up. Tenomix’s bench-top device will save time and costs by automating the process of lymph node identification in resected tissue while providing more accurate cancer staging for better patient care.

Falcons’ Fortunes 2024 – Pitch Your Cancer Innovation

Posted on January 31, 2024 (March 20, 2024)

January 31, 2024 – Apply Now! FACIT invites entrepreneurs and scientists to pitch their Ontario-made cancer innovation to a panel of judges and in front of a live audience for a chance to win the $100,000 award. Falcons’ Fortunes is FACIT’s premier event to celebrate and grow the entrepreneurial spirit within the cancer research community to drive a culture of commercialization where Ontario-based cancer research discoveries becomes Ontario-made solutions to benefit patients worldwide.

Looking ahead to 2024

Posted on January 9, 2024 (March 7, 2024)

January 9, 2024 – The FACIT team is delighted to welcome the new year! For 2024, we maintain our focus on commercializing cancer research and attracting high tech jobs to Ontario. We look forward to working together with our stakeholders and partners to create good-paying jobs, accelerate commercialization and encourage the adoption of Ontario’s innovations to improve health care and grow the economy.

Happy Holidays from FACIT

Posted on December 7, 2023 (January 9, 2024)

December 7, 2023 – Season’s Greetings!
From the Ontario life science ecosystem, your friends at FACIT wish you and your family a safe and relaxing holiday season. We look forward to working with you in the new year.

Women-led health and biotech companies dominate FACIT’s latest investments

Posted on November 20, 2023 (May 24, 2024)

November 20, 2023 – On the globally-recognized Women’s Entrepreneurship Day, FACIT is pleased to announce investments in four breakthrough oncology innovations – all driven by women leaders. November 19th each year is a day to celebrate and showcase women’s contributions to advance communities and to strengthen their empowerment in the entrepreneurial ecosystem to drive economic impact. FACIT’s support of the four ventures, Virano Therapeutics, Hyivy Health, Tenomix Inc., and DTPx Therapeutics are representative of an asset portfolio where over one third are women-led or founded innovations, attracting one third of every dollar invested by FACIT – as much as ten times the average for the venture capital industry.

cTRL Therapeutics announces new Chief Executive Officer to continue advancing its novel immune cell therapy

Posted on November 2, 2023 (March 7, 2024)

November 2, 2023 – cTRL Therapeutics (“cTRL”), a FACIT co-founded and financed company developing novel tumour cell therapies for patients living with cancer, welcomes industry veteran Derrell D. Porter, M.D., as Chief Executive Officer.

FACIT appoints seasoned life science leaders to its Board of Directors

Posted on November 1, 2023 (March 7, 2024)

November 1, 2023 – FACIT is pleased to welcome two new directors to its Board, Dr. Maura Campbell and Dr. Laszlo Radvanyi. Dedicated to commercializing Ontario intellectual property and impacting patients with cancer, both executives bring with them decades of private and public sector leadership experiences.

FACIT and T-CAIREM at the University of Toronto partner to commercialize medical AI

Posted on August 2, 2023 (March 7, 2024)

August 2, 2023 – FACIT and T-CAIREM announce partnership to commercialize medical artificial intelligence (AI) innovations. The partners intend to harness both T-CAIREM’s innovative translational research in AI and FACIT’s unique commercialization-venture model to build the next generation of Ontario biotechnology companies. The joint mission will accelerate the benefits of AI research to support patients battling cancer.

Author: Ricky

Posts by Ricky